OssDsign AB: OssDsign publishes Annual Report 2023
OssDsign AB (publ) announces that the Annual Report for 2023 is now available as a PDF on the company's website, www.ossdsign.com. A PDF version is also attached to this press release.
"We enter 2024 as a pure play orthobiologics company with full focus on the U.S. market, fortified with excellent clinical results and an expanded indication for OssDsign Catalyst®" said Morten Henneveld, CEO, OssDsign AB.